Symbol | Exchange | Currency |
|---|
March 31 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX :* EXECUTED A NEW AGREEMENT WITH BENE PHARMACHEM* NEW COLLABORATION AGREEMENT ALLOWS FOR FURTHER DEVELOPMENT OF...
March 26 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX :* SUBMITTED INVESTIGATIONAL NEW DRUG APPLICATION TO US FOOD AND DRUG ADMINISTRATION FOR STUDY WITH PPS (ZILOSUL)
Sept 29 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX :* EXTENDS TERM, INDICATIONS AND TERRITORIES UNDER EXCLUSIVE SUPPLY AGREEMENT WITH BENE PHARMACHEM
Paradigm Biopharmaceuticals Limited is a late-stage drug development company. The Company is developing and commercializing injectable Pentosan Polysulfate Sodium (PPS) for the treatment of pain associated with musculoskeletal disorders driven by injury, inflammation, aging, degenerative disease, infection, or genetic predisposition. The Company focuses on repurposing PPS for the treatment of Osteoarthritis (OA) and bone marrow lesions (BML), chronic heart failure (CHF) and alphaviral arthritis (Ross River Virus and Chikungunya). Its product candidate PPS is a non-opioid drug treatment for the chronic pain and joint stiffness of Osteoarthritis. Its product candidate PPS is providing treatment for Mucopolysaccharidosis, an inherited defect in the catabolism of sulfated components of connective tissue known as glycosaminoglycans (GAGs). Its product candidate PPS is used to treat Ross River virus and Chikungunya, an arthritogenic alphaviruses transmitted by mosquito bites.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Strong Buy | Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Sell | Strong Buy | Neutral |
| Summary | Strong Buy | Strong Buy | Neutral | Strong Buy | Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.07 | 0.08 | 0.08 | 0.00 | 0.00% | 28.52K | Sydney | |||
| 6.55 | 6.88 | 6.55 | -0.28 | -4.10% | 69.05K | Sydney | |||
| 38.49 | 39.04 | 38.475 | -0.330 | -0.85% | 4.29M | Sydney | |||
| 7.21 | 7.25 | 7.15 | -0.050 | -0.69% | 662.50K | Sydney | |||
| 2.49 | 2.54 | 2.45 | -0.03 | -1.19% | 109.50K | Sydney | |||
| 2.975 | 3.01 | 2.96 | -0.025 | -0.83% | 14.87M | Sydney | |||
| 127.60 | 128.62 | 125.11 | -4.72 | -3.57% | 106.53K | Sydney | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 0.017 | 0.017 | 0.017 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 3.14 | 3.24 | 3.13 | -0.08 | -2.48% | 186.79K | Sydney | |||
| 8.67 | 8.78 | 8.54 | +0.09 | +1.05% | 84.13K | Sydney | |||
| 2.01 | 2.05 | 1.98 | +0.030 | +1.52% | 44.98K | Sydney | |||
| 3.92 | 3.945 | 3.87 | +0.020 | +0.51% | 6.73M | Sydney | |||
| 4.79 | 4.94 | 4.76 | -0.22 | -4.39% | 930.12K | Sydney | |||
| 0.31 | 0.33 | 0.30 | -0.01 | -4.62% | 28.47K | Sydney |